Peter J. Buckley - Mar 3, 2025 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)

Role
President, International Division
Signature
/s/ Cot Eversole, Attorney-in-Fact for Peter J. Buckley
Stock symbol
CRH
Transactions as of
Mar 3, 2025
Transactions value $
-$1,348,275
Form type
4
Date filed
3/5/2025, 04:30 PM
Previous filing
Jan 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRH Ordinary Shares Award $0 +27.3K +19.14% $0.00 170K Mar 3, 2025 Direct F1
transaction CRH Ordinary Shares Tax liability -$1.35M -14.2K -8.34% $95.23 156K Mar 3, 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRH Deferred Share Award Award +3.88K 3.88K Mar 3, 2025 Ordinary Shares 3.88K $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the vesting and release of awards granted in 2022 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 2,284 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee").
F2 Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in the connection with the aforementioned awards
F3 The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $92.75 and $98.705 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request.
F4 Reflects time-based conditional awards, as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, subject to the determination of the Compensation Committee, the balance will vest in March 2028. In accordance with the DSB Plan Rules, dividend equivalents will apply to the Award and, to the extent awarded, will be reported at the time of vesting.

Remarks:

President, International Division